Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
2020 | Zeitschriftenartikel. Eine Publikation mit Affiliation zur Georg-August-Universität Göttingen.
Spring zu: Zitieren & Links | Dokumente & Medien | Details | Versionsgeschichte
Zitiervorschlag
Pudil, Radek, et al. "Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology." European Journal of Heart Failure, vol. 22, no. 11, 2020, pp. 1966-1983, doi: 10.1002/ejhf.2017.
Dokumente & Medien
Details
- Autor(en)
- Pudil, Radek; Mueller, Christian ; Čelutkienė, Jelena; Henriksen, Peter A.; Lenihan, Dan; Dent, Susan; Barac, Ana; Stanway, Susanna; Moslehi, Javid; Suter, Thomas M.; Ky, Bonnie; Štěrba, Martin; Cardinale, Daniela; Cohen‐Solal, Alain; Tocchetti, Carlo Gabriele; Farmakis, Dimitrios; Bergler‐Klein, Jutta; Anker, Markus S.; Von Haehling, Stephan ; Belenkov, Yury; Iakobishvili, Zaza; Maack, Christoph; Ciardiello, Fortunato; Ruschitzka, Frank; Coats, Andrew J.S.; Seferovic, Petar; Lainscak, Mitja; Piepoli, Massimo F.; Chioncel, Ovidiu; Bax, Jereon; Hulot, Jean‐Sebastien; Skouri, Hadi; Hägler‐Laube, Eva Simona; Asteggiano, Riccardo; Fernandez, Teresa Lopez; Boer, Rudolf A.; Lyon, Alexander R.
- Erscheinungsdatum
- 2020
- Zeitschrift
- European Journal of Heart Failure
- ISSN
- 1388-9842
- eISSN
- 1879-0844
- Sprache
- Englisch
